Lack of association of interleukin-1β gene polymorphisms in Chinese patients with systemic lupus erythematosus

被引:22
作者
Huang, CM
Wu, MC
Wu, JY
Tsai, FJ
机构
[1] China Med Coll Hosp, Dept Med Genet, Taichung, Taiwan
[2] China Med Coll Hosp, Dept Internal Med, Div Immunol & Rheumatol, Taichung, Taiwan
关键词
IL-1; beta; systemic lupus erythematosus; gene polymorphism;
D O I
10.1007/s00296-001-0164-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to examine whether interleukin-1beta (IL-1beta) (promoter and exon 5) gene polymorphisms were markers of susceptibility or clinical manifestation in Chinese patients with systemic lupus erythematosus (SLE). The study included 52 Chinese patients with SLE. In addition, 103 unrelated healthy individuals living in central Taiwan served as control subjects. From genomic DNA, polymorphisms of the gene for IL-1beta promoter and exon 5 were typed. Allelic frequencies were compared between SLE patients and control subjects. The relationship between allelic frequencies and clinical manifestations of SLE was evaluated. No significant differences were observed in the allelic frequencies of the IL-1beta promoter and IL-1beta exon 5 between patients with SLE and healthy control subjects. Additionally, we did not detect any association of IL-1beta promoter and the exon 5 genotype with the clinical and laboratory profiles in SLE patients. The results from the present study suggest that the polymorphisms of the IL-1beta promoter and IL-1beta exon 5 are not related to SLE patients in Taiwan.
引用
收藏
页码:173 / 175
页数:3
相关论文
共 22 条
  • [1] PRODUCTION OF INTRACELLULAR AND EXTRACELLULAR INTERLEUKIN-1-ALPHA AND INTERLEUKIN-1-BETA BY PERIPHERAL-BLOOD MONOCYTES FROM PATIENTS WITH CONNECTIVE-TISSUE DISEASES
    AOTSUKA, S
    NAKAMURA, K
    NAKANO, T
    KAWAKAMI, M
    GOTO, M
    OKAWATAKATSUJI, M
    KINOSHITA, M
    YOKOHARI, R
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1991, 50 (01) : 27 - 31
  • [2] INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE POLYMORPHISM AS A DISEASE SEVERITY FACTOR IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    BLAKEMORE, AIF
    TARLOW, JK
    CORK, MJ
    GORDON, C
    EMERY, P
    DUFF, GW
    [J]. ARTHRITIS AND RHEUMATISM, 1994, 37 (09): : 1380 - 1385
  • [3] STUDIES OF TWINS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - REVIEW OF LITERATURE AND PRESENTATION OF 12 ADDITIONAL SETS
    BLOCK, SR
    WINFIELD, JB
    LOCKSHIN, MD
    DANGELO, WA
    CHRISTIAN, CL
    [J]. AMERICAN JOURNAL OF MEDICINE, 1975, 59 (04) : 533 - 552
  • [4] BOSWELL JM, 1988, J IMMUNOL, V141, P3050
  • [5] BURCH PRJ, 1993, LANCET, V341, P1021
  • [6] Cantagrel A, 1999, ARTHRITIS RHEUM, V42, P1093, DOI 10.1002/1529-0131(199906)42:6<1093::AID-ANR5>3.0.CO
  • [7] 2-P
  • [8] CHROMOSOMAL LOCATION OF MURINE AND HUMAN IL-1 RECEPTOR GENES
    COPELAND, NG
    SILAN, CM
    KINGSLEY, DM
    JENKINS, NA
    CANNIZZARO, LA
    CROCE, CM
    HUEBNER, K
    SIMS, JE
    [J]. GENOMICS, 1991, 9 (01) : 44 - 50
  • [9] Di Giovine F. S., 1992, Human Molecular Genetics, V1, P450
  • [10] FAMILY STUDY OF THE MAJOR HISTOCOMPATIBILITY COMPLEX IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - IMPORTANCE OF NULL ALLELES OF C4A AND C4B IN DETERMINING DISEASE SUSCEPTIBILITY
    FIELDER, AHL
    WALPORT, MJ
    BATCHELOR, JR
    RYNES, RI
    BLACK, CM
    DODI, IA
    HUGHES, GRV
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1983, 286 (6363): : 425 - 428